This site does not support your browser.

We recommend you to upgrade to the latest version:

Resume browsing

Investors Dashboard
Contact
YouTubeLinkedinInstagramFacebookTwitter
  • English
  • Spanish
PharmaMar
PharmaMar
S.A.
  • About PharmaMar
    • About PharmaMar
    • Senior Management
    • Management Team – Oncology Unit
    • Board of Directors
    • Other Businesses
    • PharmaMar in the World
    • Awards & Recognition
    • Corporate Responsibility
    • Our History
    • Presentations
  • Patients
    • Therapeutic Indications
    • Collaboration with Patient Associations
    • Clinical trial
  • YONDELIS®
  • Science & Innovation
    • R&D and Innovation
    • Oncology pipeline
    • Cofinanced projects
    • Collaboration with Scientific Associations
    • Publications
    • Mechanisms of Action
    • Medical meeting presentations
  • Shareholders and Investors
    • Financial Information
      • Annual Reports
      • Quarterly Reports
      • Financial Statements (Zeltia)
      • Average Period of Payment to Suppliers
    • Official Notices to the CNMV
      • PharmaMar
      • Zeltia
    • Share Information
      • Share Performance
      • Shares outstanding
      • Dividends
      • Significant Shareholding & Company Owned-Stock
      • Analysts
    • Debt obligations
    • Presentations
    • General Shareholders Meetings
    • Corporate Governance
      • Corporate Bylaws
      • General Shareholders’ Meeting Regulations
      • Shareholder Agreements
      • Board of Directors
      • Board of Directors Regulation
      • Annual Report on Corporate Governance
      • Annual Director Remuneration Report
      • Board Committees
      • Internal Regulation Governing Conduct
    • Contact
    • Merger PharmaMar-Zeltia
    • Política de comunicación con accionistas
  • Newsroom
    • Press Releases
    • Events Calendar
    • Multimedia
      • Videos
      • Infographics
    • Corporate Brochure
  • Careers
MENU CLOSE back  
Financial InformationOfficial Notices to the CNMVShare InformationDebt obligationsPresentationsOncology pipelineGeneral Shareholders MeetingsCorporate GovernanceMerger PharmaMar-ZeltiaPolítica de comunicación con accionistas

Financial Information

You are here:
  1. Home
  2. Shareholders and Investors
  3. Financial Information
  4. Quarterly Reports

Shareholders and Investors

  • Financial Information
      • Annual Reports
      • Quarterly Reports >
        • Financial Statements (Zeltia)
        • Average Period of Payment to Suppliers
    • Official Notices to the CNMV
    • Share Information
    • Debt obligations
    • Presentations
    • Oncology pipeline
    • Events Calendar
    • General Shareholders Meetings
    • Corporate Governance
    • Contact
    • Merger PharmaMar-Zeltia
    • Política de comunicación con accionistas

    Quarterly Reports

    2018


    1Q2018

    1H2018

    9M2018

    2017


    1Q2017

    1H2017

    9M2017

    2017

    2016


    1Q2016

    1H2016

    9M2016

    2016

    2015


    1Q2015

    1H2015

    9M2015

    2015

    2014


    1Q2014

    1H2014

    9M2014

    2014

    2013


    1Q2013

    1H2013

    9M2013

    2013

    2012


    1Q2012

    1H2012

    9M2012

    2012

    2011


    1Q2011

    1H2011

    9M2011

    2011

    2010


    1Q2010

    1H2010

    9M2010

    2010

    Quarterly Reports

    Financial Statements (Zeltia)

    Average Period of Payment to Suppliers

    PHARMA MAR, S.A.
    VAT: ESA-78267176

    Avda. De los Reyes, 1
    Pol. Ind. La Mina
    28770 - Colmenar Viejo
    Madrid, Spain
    How to get

    34 91 846 6000
    34 91 846 6001
    pharmamar@pharmamar.com

    Legal Notice
    Privacy Policy
    Cookies Policy

    Copyright © 2019 PharmaMar - All Rights Reserved